sa-333

Captopril (SA333) is a potent and specific inhibitor of peptidyl-dipeptidase A. It blocks the conversion of angiotensin I to angiotensin II, a vasoconstrictor and important regulator of arterial blood pressure.

epi-D-Captopril (epi-D-SQ 14225) is a stereoisomer of Captopril and functions as an inhibitor of metallo-beta-lactamases (MBLs). The IC50 values of epi-D-Captopril for NDM-1, IMP-1, and VIM-2 are 64 μM, 173 μM, and 5.5 μM, respectively. This compound holds potential for research in MBLs-related antibiotic-resistant infections.

Captopril-[13C5,15N] (Standard) is a reference standard of Captopril-[13C5,15N] intended for quantitative analysis, quality control, and related biochemical research applications.

Captopril (Standard) is the standard substance of Captopril, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Captopril (SA333) is a potent and specific inhibitor of peptidyl-dipeptidase A. It blocks the conversion of angiotensin I to angiotensin II, a vasoconstrictor and important regulator of arterial blood pressure.

Captopril-D3 is a deuterated form of Captopril. Captopril (T1462) (SQ 14225), a thiol-containing orally active angiotensin-converting enzyme (ACE) inhibitor with an IC50 of 0.025 μM, is widely used in research on hypertension and congestive heart failure. Additionally, Captopril (T1462) acts as an NDM-1 inhibitor, with an IC50 of 7.9 μM.

Captopril (SQ 14225) hydrochloride is an antihypertensive agent that is a thiol-containing, competitive, orally active angiotensin-converting enzyme (ACE) inhibitor with an IC50 of 0.025 μM, widely used in hypertension and congestive heart failure research. It is also a New Delhi metallo-β-lactamase-1 (NDM-1) inhibitor with an IC50 of 7.9 μM [1] [2] [3].

Captopril disulfide, a metabolite of Captopril, is a new antihypertensive agent.